Skip to main content

Table 1 Baseline characteristics of the patients

From: A patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding

  

Office polypectomy (n = 324)

Inpatient polypectomy (n = 75)

p value

Age (years)

Mean (SD)

53 (11)

51 (12)

p = 0.2

BMI (kg/m2)

Mean (SD)

31 (8)a

31 (8)b

p = 0.7

Ethnicity

White

263 (91 %)

54 (93 %)

p > 0.9

Asian

12 (4 %)

2 (3 %)

Black

8 (3 %)

1 (2 %)

Other

6 (2 %)

1 (2 %)

Not given/not known

35

17

Recruiting centre

BWHc

105 (32 %)

24 (32 %)

p = 0.5

RHHd

60 (19 %)

18 (24 %)

Otherse

159 (49 %)

33 (44 %)

Predominant bleeding complaint at randomisation

Post-menopausalf

155 (48 %)

37 (49 %)

p = 0.2

Heavy menstrualg

75 (23 %)

23 (31 %)

Intermenstrualh

94 (29 %)

15 (20 %)

Site of uterine polyp

Fundal

118 (36 %)

25 (33 %)

p = 0.6

Non-fundal

206 (64 %)

50 (67 %)

Type of uterine polyp

Glandular

229 (71 %)

53 (71 %)

p > 0.9

Fibrous

95 (29 %)

22 (29 %)

Number of polyps

1

233 (72 %)

58 (77 %)

p = 0.6

2

62 (19 %)

11 (15 %)

> = 3

29 (9 %)

6 (8 %)

Parity

0

49 (15 %)

18 (24 %)

p = 0.4

1

35 (11 %)

6 (8 %)

2

121 (37 %)

26 (35 %)

3

50 (15 %)

9 (12 %)

> = 4

37 (11 %)

8 (11 %)

missing

32 (10 %)

8 (11 %)

Other benign pathology

None

318 (98 %)

74 (99 %)

p = 0.8

SMF/Adhesion/Septum

Adhesion/Septum

SMF

5 (2 %)

1 (1 %)

Septum

1 (<1 %)

  1. SMF submucosal fibroid
  2. aBased on 56 values
  3. bBased on 207 values
  4. cBirmingham Women’s Hospital
  5. dRoyal Hallamshire Hospital, Sheffield
  6. e28 other centres: median recruitment = 4 (IQR = [2, 9])
  7. f16 (10 %) and 3 (8 %) of these women were currently taking a continuous combined ‘no bleed’ HRT in the office and inpatient groups, respectively
  8. gIncludes one post-menopausal woman (1 %) on a sequential HRT (office group)
  9. hIncludes two post-menopausal women (2 %) on a sequential HRT (office group)